| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2024 , Vol 62 , Num 1
Assessment of patients" adherence to antihypertensive therapy in a teaching hospital in Ogun state, Nigeria
1 Department of Pharmaceutics and Pharmaceutical Technology, Federal University Oye-Ekiti, Ekiti State, Nigeria2 Department of Clinical Pharmacy and Pharmacy Administration, Federal University Oye-Ekiti, Ekiti State, Nigeria
3 Department of Pharmaceutical Chemistry. University of Benin, Benin City, Edo State, Nigeria
DOI : 10.23893/1307-2080.APS6207 Viewed : 2190 - Downloaded : 593 Adherence is important in reducing morbidity and mortality associated with uncontrolled hypertension. The aim of the study was to assess adherence of hypertensive patients to therapy. A cross sectional study was carried out on 325 patients on antihypertensive therapy. Data collection tools were modified Hill Bone medication adherence subscale and Health Belief Model scale. Descriptive statistics, Pearson correlation and Multiple Regression Analysis were employed for data analysis at 5% level of significance. Most respondents were female, (56.3%), ? 60 years (63.7%), and married (62.2%). Patients differed significantly in their adherence based on age (p=0.032) and gender (p=0.025), severity (p=0.021) susceptibility (p=0.001), benefits (0.031), barriers (p=0.015) and cue to action (p=0.010). Adherence rate of 59.1% was reported among the respondents in the study. The study outcomes highlight the need for interventions by pharmacists that promote adherence to antihypertensive medications. Keywords : hypertension, adherence, antihypertensive medication, modified Hill-Bone adherence subscale, health belief model